Clinical trial
LEVITRA® Specific Drug Use Investigation. To Investigate the Safety Profile in Combination Use With Alpha-blockers
NCT01207947 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LEVITRA® Specific Drug Use Investigation. To Investigate the Safety Profile in Combination Use With Alpha-blockers
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2007
- Completion date
- March 31, 2010
- Enrollment
- 491 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.